Håkan Widner

Author PubWeight™ 36.13‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med 2008 6.90
2 The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol 2013 2.65
3 Red flags for multiple system atrophy. Mov Disord 2008 1.75
4 Dyskinesias following neural transplantation in Parkinson's disease. Nat Neurosci 2002 1.74
5 Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease. Mov Disord 2010 1.47
6 Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry. Mov Disord 2010 1.34
7 Long-term efficacy of thalamic deep brain stimulation for tremor: double-blind assessments. Mov Disord 2003 1.24
8 Long-term neurological outcome after cardiac arrest and therapeutic hypothermia. Resuscitation 2009 1.22
9 Immune problems in central nervous system cell therapy. NeuroRx 2004 1.21
10 Health-related quality of life in multiple system atrophy. Mov Disord 2006 1.11
11 Medication report reduces number of medication errors when elderly patients are discharged from hospital. Pharm World Sci 2007 1.05
12 Accuracy and sensitivity of Parkinsonian disorder diagnoses in two Swedish national health registers. Neuroepidemiology 2012 1.05
13 Measuring fatigue in Parkinson's disease: a psychometric study of two brief generic fatigue questionnaires. J Pain Symptom Manage 2006 1.04
14 Complete ascertainment of Parkinson disease in the Swedish Twin Registry. Neurobiol Aging 2007 1.02
15 Signs of degeneration in 12-22-year old grafts of mesencephalic dopamine neurons in patients with Parkinson's disease. J Parkinsons Dis 2011 0.95
16 A Swedish family with de novo alpha-synuclein A53T mutation: evidence for early cortical dysfunction. Parkinsonism Relat Disord 2009 0.91
17 Safety and tolerability of intracerebroventricular PDGF-BB in Parkinson's disease patients. J Clin Invest 2015 0.82
18 Efficacy and safety of the dopaminergic stabilizer Pridopidine (ACR16) in patients with Huntington's disease. Clin Neuropharmacol 2010 0.82
19 Alpha-synuclein multiplications with parkinsonism, dementia or progressive myoclonus? Parkinsonism Relat Disord 2008 0.81
20 Proinflammatory cytokines are elevated in serum of patients with multiple system atrophy. PLoS One 2013 0.81
21 Clinical neurotransplantation: core assessment protocol rather than sham surgery as control. Brain Res Bull 2002 0.81
22 Intracerebral cytokine profiles in adult rats grafted with neural tissue of different immunological disparity. Brain Res Bull 2004 0.80
23 Activated porcine embryonic brain endothelial cells induce a proliferative human T-lymphocyte response. Cell Transplant 2003 0.80
24 First neuropathological description of a patient with Parkinson's disease and LRRK2 p.N1437H mutation. Parkinsonism Relat Disord 2011 0.79
25 Fulfilment of patients' goals after thalamic deep brain stimulation: a follow-up study. Parkinsonism Relat Disord 2006 0.79
26 Parkinson disease: Poor results for retinal cell transplants in Parkinson disease. Nat Rev Neurol 2011 0.78
27 Simultaneous inhibition of B7 and LFA-1 signaling prevents rejection of discordant neural xenografts in mice lacking CD40L. Xenotransplantation 2002 0.78
28 Induction of operational tolerance to discordant dopaminergic porcine xenografts. Transplantation 2003 0.77
29 [Restless legs--common but often missed disease. Successful treatment possibilities are now available]. Lakartidningen 2006 0.76
30 EXPRESSION OF PLATELET-DERIVED GROWTH FACTOR IN AND AROUND INTRASTRIATAL EMBRYONIC MESENCEPHALIC GRAFTS. Cell Transplant 1993 0.75
31 Validity and Responsiveness of At-Home Touch Screen Assessments in Advanced Parkinson's Disease. IEEE J Biomed Health Inform 2015 0.75
32 Neural Tissue Xenotransplantation: What Is Needed Prior to Clinical Trials in Parkinson's Disease? Cell Transplant 2000 0.75
33 [Therapeutic hypothermia after cardiac arrest. A cold intravenous fluid, a cooling helmet and a cooling blanket efficiently reduce body temperature]. Lakartidningen 2004 0.75